Summary
Mechanism of the cancer prevention was complicated, and the elucidation was difficult if it was a conventional experiment system. We are building the system which put the latest technology to reach a screening trial of cancer preventive agents from an approach to find candidate cell signaling pathway of cancer prevention by using combination of DNA chip technology and Cell Signaling Network Database (CSNDB) maintained by the National Institute of Health Sciences. As for these strategies, we think that it is an interesting trial when we examine the effectiveness from an interesting pathway search in investigation for an unknown cancer preventive agent. We are in the way, but demonstrate a part of our study and try to think about the future prospects.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
zur Hausen H, Bornkamm GW, Schmidt R, Hecker E (1979) Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc Natl Acad Sci USA 76: 782–785.
Yamamoto N, Bister K, zur Hausen H (1979) Retinoic acid inhibition of Epstein-Barr virus induction. Nature 278: 553–554.
zur Hausen H, O’Neill F, Freese U, Hecker E (1978) Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature 272: 373–375.
Konoshima T, Takasaki M, Ichiishi E, Murakami T, Tokuda H, Nishino H, Duc NM (1999) Cancer chemopreventive activity of majonoside-R2 from Vietnamese ginseng, Panax vietnamensis. Cancer Lett 147: 11–16.
Nishino H, Murakoshi M, Masuda M, Tokuda H, Satomi Y, Onozuka M, Yamaguchi S, Bu P, Tsuruta A, Nosaka K, Baba M, Takasuka N (1999) Suppression of lung and liver carcinogenesis in mice by oral administration of myo-inositol. Anticancer Res 19: 3663–3664.
Konoshima T, Takasaki M, Tokuda H (1999) Anti-carcinogenic activity of the roots of Panax notoginseng. II. Biol Pharm Bull 22: 1150–1152.
Colombo D, Compostella F, Ronchetti F, Scala A, Toma L, Kuchide M, Tokuda H, Nishino H (2000) Anti-tumor-promoting effects of glycoglycerolipid analogues on two-stage mouse skin carcinogenesis. Cancer Lett 20: 201–205.
Tanaka R, Ohtsu H, Iwamoto M, Minami T, Tokuda H, Nishino H, Matsunaga S, Yoshitake A (2000) Cancer chemopreventive agents, labdane diterpenoids from the stem bark of Thuja standishii (Gord.) Carr. Cancer Lett 20: 165–170.
Ito H, Koreishi M, Tokuda H, Nishino H, Yoshida T (2000) Cypellocarpins A-C, phenol glycosides esterified with oleuropeic acid, from Eucalyptus cypellocarpa. J Nat Prod 63: 1253–1257.
Ishida J, Kozuka M, Wang H, Konoshima T, Tokuda H, Okuda M, Yang Mou X, Nishino H, Sakurai N, Lee KH, Nagai M (2000) Antitumor-promoting effects of cyclic diarylheptanoids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis. Cancer Lett 31: 135–140.
Iwase Y, Takemura Y, Ju-ichi M, Ito C, Furukawa H, Kawaii S, Yano M, Mou XY, Takayasu J, Tokuda H, Nishino H (2000) Inhibitory effect of flavonoids from citrus plants on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumors. Cancer Lett 154: 101–105.
Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M Wang C, Kobayashi M, Horton H, Brown EL (1996) Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14: 1675–1680.
Wodicka L, Dong H, Mittmann M, Ho MH, Lockhart DJ (1997) Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat Biotechnol 15: 1359–1367.
Wang Y, Rea T, Bian J, Sun Y (1999) Identification of the genes responsive to etoposide-induced apoptosis: application of DNA chip technology. FEBS Lett 445: 269–273.
Takai-Igarashi T, Nadaoka Y, Kaminuma T (1998) A database for cell signaling networks. J Comput Biol 5: 747–754.
Igarashi T, Kaminuma T (1997) Development of a cell signaling networks database. Pac Symp Biocomput: 187-197.
Belman S, Troll W (1972) The inhibition of croton oil-promoted mouse skin tumorigenesis by steroid hormones. Cancer Res 32: 450–454.
Verma AK, Slaga TJ, Wertz PW, Mueller GC, Boutwell RK (1980) Inhibition of skin tumor promotion by retinoic acid and its metabolite 5,6-epoxyretinoic acid. Cancer Res 40: 2367–2371.
Der SD, Zhou A, Williams BR, Silverman RH (1998) Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotode arrays. Proc Natl Acad Sci USA 95: 15623–15628.
de Saizieu A, Certa U, Warrington J, Gray C, Keck W, Mous J (1998) Bacterial transcript imaging by hybridization of total RNA to oligonucleotide arrays. Nat Biotechnol 16: 45–48.
Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567–572.
Hurst RE, Waliszewski P, Waliszewska M, Bonner RB, Benbrook DM, Dar A, Hemstreet GP (1999) Complexity, retinoid responsive gene networks, and bladder carcinogenesis. Adv Exp Med Biol 462: 449–467.
Boudjelal M, Wang Z, Voorhees JJ, Fisher GJ (2000) Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes. Cancer Res 15: 2247–2252.
York IA, Goldberg AL, Mo XY, Rock KL (1999) Proteolysis and class I major histocompatibility complex antigen presentation. Immunol Rev 172: 49–66.
de Groot RP, Kruijer W (1991) Up-regulation of Jun/AP-1 during differentiation of N1E-115 neuroblastoma cells. Cell Growth Differ 2: 631–636.
Osterhout DJ, Wolven A, Wolf RM, Resh MD, Chao MV (1999) Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase. J Cell Biol 145: 1209–1218.
Bloch RJ, Pumplin DW (1988) Molecular events in synaptogenesis: nerve-muscle adhesion and postsynaptic differentiation. Am J Physiol 254: C345–364.
Bates ME, Bertics PJ, Busse WW (1996) IL-5 activates a 45-kilodalton mitogenactivated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils. J Immunol 156: 711–718.
Levy S, Todd SC, Maecker HT (1998) CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 16: 89–109.
Song DH, Sussman DJ, Seldin DC (2000) Endogenous protein kinase CK2 participates in Wnt signaling in mammary epithelial cells. J Biol Chem 275: 23790–23797.
Sinha P, Hutter G, Kottgen E, Dietel M, Schadendorf D, Lage H (1999) Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas. Electro phoresis 20: 2952–2960.
Fritz G, Just I, Kaina B (1999) Rho GTPases are over-expressed in human tumors. Int J Cancer 81: 682–687.
Seiler N, Atanassov CL, Raul F (1998) Polyamine metabolism as target for cancer chemoprevention. Int J Oncol 13: 993–1006.
Tanaka T, Nishimura Y, Tsunoda H, Naka M (2000) Pharmacogenomics and therapeutic target validation in cerebral vasospasm. J Cardiovasc Pharmacol 36: Suppl 2, S1–4.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Japan
About this paper
Cite this paper
Ichiishi, E., Yoshikawa, T. (2003). Screening trial of cancer chemopreventive agent by using combination of DNA chip technology and Cell Signaling Network DataBase (CSNDB). In: Inoue, T., Pennie, W.D. (eds) Toxicogenomics. Springer, Tokyo. https://doi.org/10.1007/978-4-431-66999-9_12
Download citation
DOI: https://doi.org/10.1007/978-4-431-66999-9_12
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-67001-8
Online ISBN: 978-4-431-66999-9
eBook Packages: Springer Book Archive